Hospital
RSSArticles
-
Manage Transition from ED to ICU for Better
ED volumes have risen with expanded coverage through the Affordable Care Act and are likely to remain high, putting more pressure on hospitals for an efficient process for transitioning patients from the ED to the ICU. Tracking key metrics is a first step in improving that transition process, which includes ensuring that patients are not unnecessarily admitted to the costly ICU, where few guidelines exist to establish protocols for ICU admissions and their transition of care.
-
Use Multiple Strategies for Emergency Communication
Compliance with the requirement for good communication in the CMS Condition of Participation on emergency preparedness should focus on getting information to everyone involved so that no employee is left without information in a crisis, says Brian Cruver, CEO of AlertMedia, a company in Austin, TX, that aids with emergency preparedness. In most hospitals, that will require using several different methods of communication, he says.
-
Emergency Preparedness CoP Calls for Review, Upgrading Plans
Hospitals are still moving to comply with the CMS Conditions of Participation on emergency preparedness, which became effective in late 2016, and some are finding that the plans they had in place previously are not quite enough to meet the CMS expectations.
-
Teleconsent Boosts Recruitment of Rural Research Participants
One barrier to recruitment of qualified research participants for clinical trials is the cumbersome, time-consuming consent process. Another is the lack of access to participants in remote locations.
-
Military IRBs May Err on the Side of Bureaucracy
Military IRBs may “err on the side of bureaucracy,” but the delays can place unnecessary burdens and risks on human research subjects.
-
Clinical Trials: More is Not Necessarily Better
While one may reasonably assume that more clinical research could increase the likelihood of medical breakthroughs, a contrarian’s view is that the effect could be quite the opposite — and it falls to IRBs to intervene and reduce the risks of the current glut of trials.
-
Inexact Science: The Complicated Quest To Replicate Research
A deeper look into the actual mechanics necessary to reproduce a trial reveals a process that is beset by variables that make clear conclusions difficult.
-
Strategies to Better Manage Noncompliance
The IRB at the Biomedical Research Alliance of New York in Lake Success, NY, noticed a problematic trend of researchers amending their studies in the continuing review reports.
-
Final Common Rule Is An Improvement, But Leaves Some Questions Unanswered
There were many changes between the Notice of Proposed Rulemaking and the final rule, and even more changes since the Advanced Notice of Proposed Rulemaking, which is a good thing, IRB experts say.
-
Common Rule Change Took Six Years to Complete — And Could Be Upended in 30 Seconds
After six years of debate, criticism, and waiting, the 543-page Common Rule looks a lot better than the original proposal in 2011, but the biggest question now is whether the work will be upended with the stroke of a pen.